Clinical Implementation of Total-Body PET/CT at University of California, Davis.
This work outlines the clinical implementation of total-body PET/CT from the time of installation at UC Davis EXPLORER Molecular Imaging Center in May 2019 to date (September 2020). This process has not been without challenges: logistical, technical, and medical problems were all encountered and are discussed. The mutual learning/teaching engagement among nuclear medicine technologists, research staff, radiologists, and referring physicians has been the key to the past year's achievements; these include development of ground-breaking clinical protocols for a range of Food and Drug Administration-approved radiotracers, and the attainment of a measure of expertise in clinical total-body PET/CT.
['Nardo|Lorenzo|L|', 'Abdelhafez|Yasser G|YG|', 'Spencer|Benjamin A|BA|', 'Badawi|Ramsey D|RD|']
D002140:California D019788:Fluorodeoxyglucose F18 D005710:Gallium Radioisotopes D006801:Humans D000072078:Positron Emission Tomography Computed Tomography D019275:Radiopharmaceuticals D012680:Sensitivity and Specificity D014495:Universities D051598:Whole Body Imaging
Total-body PET Human imaging Positron emission tomography